Table of Contents
Licensing
| Vertex Augments Cystic Fibrosis Pipeline with Parion Sciences Deal | Abstract html |
| Heather Cartwright & Hardik Mewada |
| Celgene Raises the Bar in Immuno-Oncology with US$1 B Bet on JunoTherapeutics | Abstract |
| Heather Cartwright & Rohit Khera |
This work is licensed under a Creative Commons Attribution 3.0 License.